This content has been archived. It may no longer be relevant
HEKzeroT® for AAV and biologics production
ExcellGene’s HEKzeroT® has been genetically modified to eliminate the SV40 T DNA sequence. The clonally derived cell line has been selected for the highest productivity of AAV and the highest percentage of filled particles.
High Cell Density in Bioreactors
>15 million cells/mL, > 98% viability
Robust and Non-Aggregated Cell Morphology
Doubling time of 20h
AAV Yields up to 1015 vg/L
Excellent particle filling
Accelerate the development of your gene therapy programs by using HEKzeroT® and ExcellGene’s expertise for efficient and cost-effective manufacturing solutions.
High density, non-clumping
High sub-cultivation ratios
HEKzeroT® with ExcellGene
Each project is customized to client needs and handled by a dedicated team.
We’re deeply committed to achieving your milestones, timelines, and target yields.